Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05700799 · ClinicalTrials.gov registry record · NA
HEalth Advocate for Liver Transplant - Pilot
A NA study of Pediatric ALL and Liver Transplant, Complications, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05700799: Recruiting NA study of Pediatric ALL and Liver Transplant, Complications, sponsored by University of California, San Francisco.
NCT05700799 is a NA study of Pediatric ALL and Liver Transplant, Complications that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 10 participants, below the 1,648-participant average among 21 other Pediatric ALL trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05700799, a NA study of Pediatric ALL and Liver Transplant, Complications, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The Health Advocate for Liver Transplant (HEAL-Tx) Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for pediatric liver transplant patients and measure acceptability and feasibility according to RE-AIM.
Primary Outcome
The investigators will administer a survey of caregiver experiences at study enrollment and at the end of the intervention to assess for changes in caregiver experience with the transplant team. These questions will focus on experiences receiving transplant care, experiences discussing social needs with the transplant team, and overall caregiver subjective assessment of the transplant recipient's overall health.
Conditions Studied
Interventions
- BEHAVIORAL Health Advocate
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-03-20 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT05700799 shows while recruiting
NCT05700799 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,648-participant average among 21 other Pediatric ALL trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Pediatric ALL appearing as the primary indexed condition, and to 1 intervention - of which Health Advocate is the first listed.
NCT05700799 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05700799 about?
NCT05700799 is a clinical study titled "HEalth Advocate for Liver Transplant - Pilot". The Health Advocate for Liver Transplant (HEAL-Tx) Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team. Across studies, health advocate roles vary, and can in...
What is the current status of trial NCT05700799?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2023-03-20. Estimated completion is 2027-06-30.
What conditions does trial NCT05700799 study?
This clinical trial studies the following conditions: Pediatric ALL, Liver Transplant, Complications.
What interventions are being tested in trial NCT05700799?
The interventions under investigation include: Health Advocate (BEHAVIORAL).
Who is sponsoring clinical trial NCT05700799?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05700799 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric ALL
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05700799's enrollment target sits among peer trials
10 22nd of 21 the lowest of 21 other Pediatric ALL trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric ALL trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
-
PRotein Optimization With eXercise to Improve MUscle Mass and Functional outcomeS
RECRUITING · NA
-
Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
RECRUITING · NA
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
Multicenter HomeVENT: Home Values and Experiences Navigation Track
RECRUITING · NA
-
Evaluation of Pediatric eCART Implementation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI